Results 261 to 270 of about 8,017,739 (402)

Microplanning improves stakeholders' perceived capacity and engagement to implement lymphatic filariasis mass drug administration. [PDF]

PLoS Negl Trop Dis
Worrell CM, Brant TA, Javel A, Denis E, Fayette C, Monestime F, Knowles E, Bennett C, Utzinger J, Odermatt P, Lemoine JF.   +10 more
europepmc   +1 more source

Response of The Food Administration To The Antibiotic Problem in Animals and Drug Resistance

, 1979
Lester M. Crawford
openalex   +2 more sources

Effects of Non‐Aspirin Nonsteroidal Anti‐Inflammatory Drugs on Acute Intracerebral Hemorrhage

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite celecoxib, a cyclooxygenase‐2 inhibitor, promoting functional recovery from intracerebral hemorrhage (ICH) by reducing inflammation‐mediated perihematomal edema in rat models, the evidence of its effects on patient outcomes remains limited.
Shin‐Joe Yeh, Sung‐Chun Tang, Li‐Kai Tsai, Jiann‐Shing Jeng   +3 more
wiley   +1 more source

Hardly a Windfall: Prescribing Practices in Pediatric Heart Failure Around Food and Drug Administration Approval. [PDF]

JACC Adv
Ludomirsky AB, Edelson JB, Lin KY, Berger JH, O'Connor MJ, Wittlieb-Weber CA, Griffis H, Zhang B, Rossano JW.   +8 more
europepmc   +1 more source

Dry Cow Therapy: Effects of Method of Drug Administration on Occurrence of Intramammary Infection

, 1986
R.L. Boddie, S.C. Nickerson
openalex   +1 more source

Effects of Pharmacologic and Nonpharmacologic Interventions for the Management of Sleep Problems in People With Fibromyalgia: Systematic Review and Network Meta‐Analysis of Randomized Controlled Trials

Arthritis Care &Research, EarlyView.
Objective Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain and fatigue. Almost everyone with fibromyalgia has sleep problems. We aimed to evaluate the effectiveness and safety of current interventions for the management of fibromyalgia‐related sleep problems.
Jemma Hudson, Mari Imamura, Clare Robertson, Daniel Whibley, Lorna Aucott, Katie Gillies, Paul Manson, Debra Dulake, Abhishek Abhishek, Nicole K. Y. Tang, Gary J. Macfarlane, Miriam Brazzelli   +11 more
wiley   +1 more source

Metabolic Consequences of Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Patients with rheumatoid arthritis (RA) may have metabolic disruption, which can contribute to adverse long‐term outcomes, for multiple reasons. Patients with RA appear to have a higher risk of sarcopenia, type 1 and type 2 diabetes mellitus, metabolic syndrome, and hypertension. Systemic inflammation in RA can cause a “lipid paradox,” with reduced low‐
Stevie Barry, Emily Sheng, Joshua F. Baker   +2 more
wiley   +1 more source

Evidence available and used by the Food and Drug Administration for the approval of orphan and nonorphan drugs. [PDF]

Health Aff Sch
Koong AJ, Irvin VL, Narayan A, Song S, Kaplan RM.   +4 more
europepmc   +1 more source

Risk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: A Propensity Score–Matched Cohort Study

Arthritis Care &Research, EarlyView.
Objective The objective of this study was to evaluate and compare the risk of hepatotoxicity associated with the use of febuxostat and benzbromarone in patients with gout. Methods New users of febuxostat or benzbromarone with monitoring of liver function at least three times in a year after initiation of the study drugs were identified from an ...
Wenyan Sun, Lingling Cui, Robert Terkeltaub, Ying Chen, Xinde Li, Xiaoyu Cheng, Tian Liu, Nicola Dalbeth, Changgui Li   +8 more
wiley   +1 more source

Identifying key aspects to enhance predictive modeling for early identification of schistosomiasis hotspots to guide mass drug administration. [PDF]

PLoS Negl Trop Dis
Chen Y, Luo F, Martinez L, Jiang S, Shen Y.   +4 more
europepmc   +1 more source